Related Experiment Video
Updated: May 29, 2026
06:48
Quantitative Real-Time Polymerase Chain Reaction Evaluation of MicroRNA Expression in Kidney and Serum of Mice with Age-Dependent Renal Impairment
Published on: April 29, 2022
Circulating microRNA expression is reduced in chronic kidney disease
Calida S Neal1, Michael Z Michael, Letitia K Pimlott
1Department of Renal Medicine, School of Medicine, Flinders University, Flinders Medical Centre, Adelaide, Australia.
Summary
Circulating microRNAs (miRNAs) decrease in severe chronic kidney disease. These miRNA levels correlate with kidney function, suggesting their potential as biomarkers for renal impairment.
Area of Science:
- Molecular biology and genetics
- Nephrology and renal medicine
Background:
- MicroRNAs (miRNAs) are key gene expression regulators involved in kidney development and disease.
- miRNAs are present in biological fluids like blood and urine, indicating potential roles in cell signaling and as disease biomarkers.
Purpose of the Study:
- To investigate the levels of circulating miRNAs in patients with varying stages of chronic kidney disease (CKD).
- To explore the relationship between miRNA levels and CKD severity, including patients undergoing maintenance hemodialysis.
Main Methods:
- Quantification of circulating miRNA levels in patient cohorts with different stages of chronic renal failure.
- Comparison of miRNA levels between patients with severe CKD, mild renal impairment, and normal renal function.
Main Results:
- Patients with severe chronic renal failure exhibit significantly reduced levels of total and specific circulating miRNAs.
- A strong positive correlation was observed between circulating miRNA levels and estimated glomerular filtration rate (eGFR).
- Weaker correlations were found between miRNA levels and other CKD indicators like anemia and hyperparathyroidism.
Conclusions:
- Circulating miRNAs show promise as potential biomarkers for assessing renal impairment.
- The observed changes in miRNA levels have implications for understanding the pathogenesis of uremia in CKD patients.
Related Concept Videos
01:25Chronic Kidney Disease I: Introduction
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
01:24Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
01:28Chronic Kidney Disease III: Interprofessional Care
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
01:28Diabetic Nephropathy
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...